Growth of recombinant equine herpesvirus 1 (EHV-1) replaced with passage-induced mutant gene 1 and gene 71 derived from an attenuated EHV-1 in cell cultures and in the lungs of mice.
The relationship of passage-induced mutant genes 1 and 71 of an attenuated equine herpesvirus 1 (EHV-1) with virulence was analysed by constructing nine recombinant EHV-1 viruses by homologous recombination. Gene 1 or/and gene 71 of a virulent EHV-1 strain, HH1, was replaced by a mutant gene 1 or/and 71 of an attenuated HH1 strain, BK343, respectively. The beta-galactosidase gene of Escherichia coli was inserted within the gene 1 or 71 coding sequence of HH1 to inactivate the genes. Virus replications of these recombinant viruses in cell cultures were similar, but release of the gene 71-inactivated virus from infected cells was delayed compared to that of the other viruses. Plaque sizes of the recombinant viruses were similar to those of HH1, but those of BK343 were significantly smaller, indicating an effect of some unknown factor(s) on viral cell-to-cell spread. The growth abilities of the recombinant viruses with a mutant gene 1 or/and 71 in lungs of mice were similar to those of HH1, but those of gene 71-inactivated viruses were reduced to the level of BK343 and the titers were about 100-times lower than those of the other recombinant viruses. These results indicate that the mutant genes 1 and 71 of BK343 might not confer an attenuated nature to EHV-1.
Kirisawa
Rikio
R
Department of Veterinary Microbiology, School of Veterinary Medicine, Rakuno Gakuen University, Ebetsu, Hokkaido 069-8501, Japan. r-kirisa@rakuno.c.jp
Kobayashi
Takeshi
T
Uematsu
Rumiko
R
Ikeda
Atushi
A
Kuroiwa
Rikiya
R
Urakami
Akiko
A
Iwai
Hiroshi
H
D000595:Amino Acid Sequence; D000818:Animals; D015153:Blotting, Western; D004274:DNA, Recombinant / Q000235:genetics; D005260:Female; D005814:Genes, Viral / Q000276:immunology; D006566:Herpesviridae Infections / Q000276:immunology / Q000662:veterinary* / Q000821:virology; D004861:Herpesvirus 1, Equid / Q000235:genetics* / Q000276:immunology / Q000472:pathogenicity*; D006734:Horse Diseases / Q000276:immunology / Q000821:virology*; D006736:Horses; D051379:Mice; D008807:Mice, Inbred BALB C; D008969:Molecular Sequence Data; D016254:Mutagenesis, Insertional; D016415:Sequence Alignment; D014613:Vaccines, Attenuated / Q000235:genetics / Q000276:immunology; D015678:Viral Structural Proteins / Q000235:genetics / Q000276:immunology; D014765:Viral Vaccines / Q000235:genetics / Q000276:immunology; D014774:Virulence; D014779:Virus Replication
D004274:DNA, Recombinant; D014613:Vaccines, Attenuated; D015678:Viral Structural Proteins; D014765:Viral Vaccines